Clinical evaluation of cefozopran in the field of surgery
We studied the clinical efficacy of cefozopran (CZOP), a newly developed injectable cephalosporin with a broad antibacterial spectrum, in surgical infections. The clinical efficacy was determined in 8 cases: cholangitis (1), localized peritonitis (2), subdiaphragmatic abscess (1), intraabdominal inf...
Saved in:
Published in: | CHEMOTHERAPY Vol. 41; no. Supplement4; pp. 656 - 658 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English Japanese |
Published: |
Japanese Society of Chemotherapy
1993
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We studied the clinical efficacy of cefozopran (CZOP), a newly developed injectable cephalosporin with a broad antibacterial spectrum, in surgical infections. The clinical efficacy was determined in 8 cases: cholangitis (1), localized peritonitis (2), subdiaphragmatic abscess (1), intraabdominal infection (1) and postoperative wound infection (3). CZOP was administered by intravenous drip infusion at a dose of 0.5-1 g twice daily for 3-11 days. The clinical efficacy was good in 4 patients, fair in 2 and poor in 2, showing an overall efficacy rate of 4/8. No adverse drug reactions or abnormal laboratory changes were observed. |
---|---|
ISSN: | 0009-3165 1884-5894 |
DOI: | 10.11250/chemotherapy1953.41.Supplement4_656 |